A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found.

A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report.

A small urine leak might doesn't mean bladder pressure tests are necessary, according to results from the first randomized clinical trial assessing their effectiveness.

Identifying genetic mutations in urine could help detect bladder cancer years before symptoms arise, a new study presented Friday at the European Association of Urology annual congress in Milan found.

A test that detects a biomarker in urine samples has shown excellent performance for the detection of bladder cancer in two independent studies.

Researchers have developed a test for urine, gathered during a routine procedure, to detect DNA mutations identified with urothelial cancers.

Data published in the Journal of Urology demonstrate Veracyte’s Decipher Bladder test can identify tumors most likely to respond to chemotherapy ...

Bright Uro Inc. this month received Food and Drug Administration approval for its first product, the Glean Urodynamics System.

Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, and the University of Birmingham have partnered to develop a ...

For patients with the most serious form of bladder cancer, the standard of care has been to completely remove the bladder and adjacent organs. Now scientists at Massachusetts General Hospital have ...

A new test that identifies which bladder cancer tumors will become invasive could help reduce health care costs and over-treatment in patients.

Bladder EpiCheck is a CE approved urine test for monitoring bladder cancer that was clinically validated in several independent cohorts in leading hospitals and labs throughout Europe.